ARE Patent Law Alert:
Prometheus Labs v. Mayo Clinic: Federal Circuit Applies Transformation Prong of In re Bilski Test and Finds Drug Usage Method Claim to be Patentable Subject Matter Under Section 101
(September 17, 2009) On September 16, 2009, the U.S. Court of Appeals for the Federal Circuit issued another decision addressing the scope of patent-eligible subject matter under 35 U.S.C. § 101. In Prometheus Labs., Inc. v. Mayo Collaborative Servs., No. 2008-1403 (Fed. Cir. 2009), a unanimous panel reversed the lower court’s finding that the claims […]
In The Press:
The Heshel School Builds its Portfolio of Intellectual Property
Click Charles R. Macedo, a partner at the patent law firm of Amster, Rothstein & Ebenstein, LLP, and his associate, Mark Berkowitz.
ARE Patent Law Alert: Prometheus Labs v. Mayo Clinic: Federal Circuit Applies Transformation Prong of In re Bilski Test and Finds Drug Usage Method Claim to be Patentable Subject Matter Under Section 101
(September 17, 2009) On September 16, 2009, the U.S. Court of Appeals for the Federal Circuit issued another decision addressing the scope of patent-eligible subject matter under 35 U.S.C. § 101. In Prometheus Labs., Inc. v. Mayo Collaborative Servs., No. 2008-1403 (Fed. Cir. 2009), a unanimous panel reversed the lower court’s finding that the claims […]
In The Press:Technology Transfer Tactics turns to Partner Charles R. Macedo for insight on Bilski decision.
Click here to read the article. Charles R. Macedo Esq., a partner at New York’s Amster Rothstein & Ebenstein LLP, tells TTT that the decision “keeps in play a wider range of potentially patent-eligible subject matter than if Justice Stevens’ concurrence had been adopted as a majority decision. The flexibility of the majority decision will […]